Mariam Sharman

Publisher

Mariam Sharman
Proposted By Xpylon News Medical Update

Serum Institute Invests $68M in Oxford Biomedica, Boosting UK Manufacturing

📈 Investment Details: The Serum Institute of India, the world’s largest vaccine maker, has acquired a 3.9% stake in London-listed Oxford Biomedica (OXB.L) for £50 million ($68 million). This investment will fund the expansion of Oxford Biomedica's 84,000 sq. ft manufacturing facility, Oxbox, in Oxford.


💹 Share Purchase: The Serum Institute will buy 3.4 million newly issued shares at 1,478 pence each, reflecting Oxford Biomedica's closing price on Tuesday.


👥 Job Creation: The partnership is expected to create up to 120 new jobs.


📊 Company Growth: Oxford Biomedica, known for its role in COVID-19 vaccine production for AstraZeneca, reported a revenue increase to £81.3 million in the first half of the year, doubling from £34 million in the same period last year. It swung to a pre-tax profit of £19.2 million from a previous loss of £6.1 million.


📈 Stock Reaction: Oxford Biomedica’s shares rose 6% following the announcement.



Expand for more details
Medical
Uk
News
Investment
Biomedica
Oxford
Like
Khatia Kadagidze
Message
Share
Forward